- £1.02bn
- £984.36m
- $1.19bn
- 43
- 63
- 41
- 44
REG - Indivior PLC - Indivior PLC Files 2024 Annual Report on Form 10-K
AnnouncementREG - Indivior PLC - Total Voting Rights
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC Morgan Stanley - Holding(s) in Company
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Director/PDMR Shareholding
AnnouncementREG - Indivior PLC - Joseph Ciaffoni Appointed Chief Executive Officer
AnnouncementREG - Indivior PLC Morgan Stanley - Holding(s) in Company
AnnouncementREG - Indivior PLC - FDA Approval of SUBLOCADE Label Changes
AnnouncementREG - Indivior PLC - Final Results
AnnouncementREG - Indivior PLC - Delayed FDA Approval of SUBLOCADE Label Changes
AnnouncementREG - Indivior PLC - Notice of Results
AnnouncementREG - Indivior PLC - Transaction in Own Shares
AnnouncementREG - Indivior PLC - Completion of Share Repurchase Program
AnnouncementREG - Indivior PLC - Total Voting Rights
AnnouncementREG - Indivior PLC - Appointment of Independent Non-Executive Director
AnnouncementREG - Indivior PLC - Dr. David Wheadon appointed Chair of the Board
AnnouncementREG - Indivior PLC Morgan Stanley - Holding(s) in Company
Announcement